Annete Njue, PhD

Senior Director, Market Access and Outcomes Strategy

PhD, Molecular Biology
McGill University, Montreal, Canada

MSc, Applied Parasitology and Medical Entomology
University of Liverpool, Liverpool, United Kingdom

University of Nairobi, Nairobi, Kenya

Annete Njue, PhD, is a Senior Director of Market Access and Outcomes Strategy in Manchester, United Kingdom at RTI-HS. She has over 13 years of experience working in market access and medical communications. Dr. Njue is involved in leading and writing systematic and targeted literature reviews and value dossiers to support products in a variety of therapy areas. She is also involved in preparing health technology assessment (HTA) submissions for the National Institute for Health and Clinical Excellence (NICE), the Scottish Medicines Consortium (SMC), and the National Centre for Pharmacoeconomics (NCPE). She has experience in a broad range of therapy areas, including cardiovascular disease, diabetes, hematological disorders, infectious diseases, oncology (breast, lung, prostate, colorectal cancer, myeloma), mental health, ocular conditions, renal disease, reproductive disorders, and respiratory disorders. Before joining RTI HS, Dr. Njue was a Senior Medical Writer at Prime Medica Ltd. Dr. Njue previously worked in veterinary research in Canada and Kenya, and published her work in Journal of Neurochemistry, Parasitology, and Parasitology Research.

Send Annete Njue a message

Each document must be under 2 MB.
Maximum 3 files.
2 MB limit.
Allowed types: pdf, doc, docx, xls, xlsx, txt.

By submitting this form, you accept the RTI-HS privacy policy.